Welcome to our dedicated page for Anterix SEC filings (Ticker: ATEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Anterix Inc. filings document the company’s 900 MHz private wireless broadband spectrum business, including material-event reports on spectrum license sale agreements, operating and financial results, Regulation FD updates, and capital-structure disclosures. The records include disclosures tied to broadband license sales, narrowband-to-broadband license exchanges, spectrum clearing costs, contracted proceeds, and the Demonstrated Intent key performance indicator.
The company’s SEC filings also cover governance matters, executive compensation and severance arrangements, shareholder voting matters, risk factors, and regulatory developments affecting broadband use of the 900 MHz band. Material agreements involving its wholly owned subsidiary, PDV Spectrum Holding Company, LLC, are documented through Form 8-K exhibits and related event disclosures.
Anterix Inc. director and President & CEO Scott A. Lang reported an open-market sale of company stock. On June 18, 2026, he sold 170 shares of Anterix common stock at an average price of $80.25 per share. After this transaction, he directly holds 76,527 shares of common stock, so the sale reflects only a small portion of his reported direct position.
Anterix Inc.’s Chief Financial Officer Elena Marquez reported an open‑market sale and an option exercise involving the company’s common stock. On June 17, 2026, she sold 4,291 shares at $79.50 per share and exercised stock options for 1,226 shares at $40.00 per share. Following these transactions, she directly holds 18,387 shares of common stock and 2,454 stock options. The option grant referenced in the filing vests in three equal annual installments beginning on October 4, 2025.
Anterix Inc. Chief Regulatory & Communications Officer Christopher Guttman-McCabe reported a combination of option exercises and share sales in Anterix common stock. On June 15, 2026, he exercised stock options to acquire a total of 122,852 common shares at strike prices between $25.75 and $49.39 per share.
On the same date, he executed open-market sales totaling 91,437 common shares at weighted average prices ranging from about $81.32 to $84.29 per share, across multiple price ranges noted in the footnotes. Following these transactions, one reported entry shows he directly owned 77,807 common shares. The filing also states that the option shares involved in these exercises were fully vested.
Anterix Inc. Chief Legal Officer & Corporate Secretary Gena L. Ashe exercised stock options and sold common stock in a series of transactions dated June 15, 2026. She exercised options covering 29,368 shares of common stock at strike prices of $34.96 and $49.39 per share.
To pay the exercise prices and related taxes on a cashless basis, the issuer withheld a total of 15,657 shares at $82.50 per share, which the filing clarifies did not involve open‑market sales. Ashe also completed open‑market sales totaling 17,711 shares at weighted average prices of about $81.04 and $82.14 per share. One reported sale left her with 9,531 shares held directly.
Anterix Inc. President and CEO Scott A. Lang exercised stock options and settled related obligations in shares. On June 15, 2026, he exercised options to acquire 63,788 shares at $30.99 per share and 74,530 shares at $34.96 per share. The company withheld 39,621 and 48,470 shares, respectively, to pay the exercise prices and cover income tax withholding, which the filing states did not involve any open market sales.
Anterix Inc. director Mark Fleischhauer reported an open-market sale of 3,500 shares of Common Stock on June 15, 2026 at an average price of $79.8294 per share. Following this transaction, he directly holds 12,769 Anterix common shares.
Anterix Inc. director Mahvash Yazdi reported selling 7,000 shares of Common Stock at $80.00 per share in an open-market transaction. After this sale, she directly holds 19,407 shares. She also indirectly holds 750 shares through a 401(k) and 250 shares through the Yazdi Family Trust, where she serves as trustee and disclaims beneficial ownership beyond her pecuniary interest.
The filing is a Form 144 notice reporting proposed sales of Common stock by an issuer-affiliated account and related option exercise activity. The entry list shows multiple restricted stock entries and a Stock Option Exercise on 06/17/2026 with a quantity of 1,226 shares; other listed quantities include 554, 459, 541, 905 and 606 shares tied to various grant or vesting dates.
The header also includes numeric fields shown as 341134.50 and 18732889 alongside a broker address and the exchange NASDAQ; the document lists the broker as Morgan Stanley Smith Barney LLC. This filing reports planned dispositions and related issuer-side exercises/vesting; timing and full proceeds treatment are the items shown in the listed rows.